US Patent Issued to Novartis, Immutep on April 14 for "Combination therapies comprising antibody molecules to LAG-3" (American, French Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,777, issued on April 14, was assigned to Novartis AG (Basel, Switzerland) and Immutep S.A.S. (Orsay, France).

"Combination therapies comprising antibody molecules to LAG-3" was invented by Glenn Dranoff (Sudbury, Mass.), Frederic Triebel (Versailles, France), Chrystelle Brignone (Chatenay-Malabry, France), Walter A. Blattler (Brookline, Mass.), Jennifer Marie Mataraza (Cambridge, Mass.), Catherine Ann Sabatos-Peyton (Waban, Mass.), Hwai Wen Chang (San Marcos, Calif.) and Gerhard Johann Frey (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Combination therapies comprising antibody molecules that specifically bind to LAG-3 are disclosed. The...